Uday Aditya Sarkar

Employment

• Dana-Farber Cancer Institute/ Harvard Medical School Research Fellow
  2023 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Metabolic Reprogramming of B Cells in Cancer: Effects of Altered Energetics
  Biology 2026 DOI: 10.3390/biology15100744
  +Save
• WITHDRAWN: Canonical NF-κB regulator CYLD mutations reinforce RelB mediated disease pathogenesis in Multiple Myeloma
  2026 DOI: 10.64898/2026.02.01.703152
  +Save
• Sertad1 is elevated and plays a necessary role in neuron loss and cognitive impairment in a mouse model of Alzheimer's disease
  Journal of Biological Chemistry 2025 DOI: 10.1016/j.jbc.2025.110875
  +Save
• Loss of CYLD promotes splenic marginal zone lymphoma
  HemaSphere 2025 DOI: 10.1002/hem3.70098
  +Save
• NF-kappaB Activating Pathways in Multiple Myeloma
  National Institute of Immunology 2022
  +Save
• An epithelial Nfkb2 pathway exacerbates intestinal inflammation by supplementing latent RelA dimers to the canonical NF-κB module
  Proceedings of the National Academy of Sciences 2021 DOI: 10.1073/pnas.2024828118
  +Save
• NCoR1: Putting the Brakes on the Dendritic Cell Immune Tolerance
  iScience 2019 DOI: 10.1016/j.isci.2019.08.024
  +Save
• Immune Differentiation Regulator p100 Tunes NF-κB Responses to TNF
  2019 DOI: 10.3389/fimmu.2019.00997
  +Save
• The NF-κB Activating Pathways in Multiple Myeloma
  2018 DOI: 10.3390/biomedicines6020059
  +Save